Stocks to Watch on Thursday

Lululemon Athletica Inc. (NASDAQ:LULU) shares took a hard hit before the bell, after the yoga wear retailer posted an upbeat first quarter revenues and profit of $0.34 per share, beating the estimates of $0.32. However, the apparel brand lost it in terms of coming in line for its comparable store sales and full-year outlook. Lululemon Athletica Inc. (NASDAQ:LULU) has now projected revenue  estimates of $1.77 billion to $1.8 billion for the full year, as against the earlier estimates for $1.77 billion to $1.82 billion.

Lululemon Athletica inc. (NASDAQ:LULU)

In its new move to appease advertisers, Facebook Inc (NASDAQ:FB) announced to expand the range of information that advertisers cannot access in order to target users. The social giant will now add external website and mobile app data to be accessed by its advertisers in order to help them deliver relevant ads to the Facebook Inc (NASDAQ:FB) users.

DDR Corp (NYSE:DDR) is joining hands with a unit of Blackstone in order to acquire 76 shopping centers from American Realty Capital for a total consideration worth $2 billion.

Johnson & Johnson (NYSE:JNJ) is partnering with a GlaxoSmithKline unit, ViiV Healthcare, to formulate a new AIDS drug that will combine the two drugs into one pill.

In a positive development, Hewlett-Packard Company (NYSE:HPQ)’s stock got re-rated from “Sell” to “Neutral” by Goldman Sachs. The company re-rated the stock after successful execution of plans by Hewlett-Packard Company (NYSE:HPQ)’s management.

Lands’ End, Inc. (NASDAQ:LE), which has recently spun off from Sears Holdings, has posted a first quarter profit of $0.34 per share coupled with higher revenues, in comparison to its previous year.

Geron Corporation (NASDAQ:GERN) finds big relief from the FDA’s lift of the hold on its study involving the blood cancer treatment drug, Imetelstat. In March, the FDA had placed a hold on the study amid fears that its drug might cause liver damage.

Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) posted positive results from their phase 3 trial of a new treatment aimed for rheumatoid arthritis.

Restoration Hardware Holdings Inc (NYSE:RH) posted first quarter earnings of $0.18 per share, which is higher than the market consensus of $0.11 per share. The company reported revenues above the market expectations as well as the current quarter guidance. In addition to this, the retailer of home goods said that it is outpacing the industry in general, by a substantial margin.

Amazon.com, Inc. (NASDAQ:AMZN) is launching a streaming music service that its members under $99 per year Amazon Prime program will get for free.

Intel Corporation (NASDAQ:INTC) lost $1.44 billion by paying a fine in Europe in its legal battle against rival Advanced Micro Devices.

Twitter Inc (NYSE:TWTR) went through a management reshuffling ad its COO, Ali Rowghani has resigned from his position.

Goldman Sachs Group Inc (NYSE:GS) will have to cough out as much as $67 million to resolve a suit alleging collusion among private equity firms. The suit had alleged the role of PE firms, who mutually agree to not to outbid in buyouts.

Infosys Ltd ADR (NYSE:INFY) had named Vishal Sikka as its new chief executive officer, who is a former SAP executive. Moreover, the executive chairman, Narayana Murthy will step down.

Tibco Software Inc. (NASDAQ:TIBX) has responded to a letter from its shareholder, Praesidium Investment management, stating that the company is keen to unlock value and welcomes constructive input.

Disclosure: none

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!